FDA OKs First Drug for Liver Disease-Related Pruritus

Published Date: 11 May 2026

Linerixibat approved for cholestatic itch in primary biliary cholangitis

Read Full News

Latest News

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Latest News

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

News All Time

Abivax's Inflammatory Bowel Drug Meets Main Goal Of Late Stage Trial

Abivax said on Monday its experimental drug for patients with ulcerative colitis, a type of chronic inflammatory disease, met ⁠the main goal of a closely watched late-stage...

Sacroiliitis Worsening Commonly Found in Psoriatic Arthritis

A new study has uncovered factors associated with sacroiliitis progression in patients with psoriatic arthritis, as well as protective factors such as use of biologic and targeted DMARDs.

Birch Extract Boosts Wound Healing in EB: Long-Term Data

Oleogel-S10 accelerates wound healing and reduces wound burden in children with epidermolysis bullosa, a study finds.

US CDC Flags Health Risks Linked to Travel-related Cosmetic Procedures

The U.S. Centers for Disease Control and Prevention said on Tuesday that many Americans suffered serious complications — ⁠including bacterial infections and, in some cases,...

Camp Victory: Support, Connections for Kids With Vitiligo

A unique camp brings together children and youth with vitiligo and their parents to talk about their challenges. They don’t want to leave.

Doctor Helps Woman Stop Blaming Herself and Accept Treatment

When an oncologist learns one patient’s story, everything shifts, including his approach to consultations.

IBS: New Dietetic Guidance Advises to ‘Think Beyond Diet’

Updated BDA guidance moves away from a diet-first approach to IBS, urging dietitians to consider lifestyle, mental health, and nondietary factors.

From K-pop to K-glow: Lasers, Face Firming Drive S Korea Tourism

Just over 2 million foreigners visited South Korea last year for medical treatment, nearly double the 2024 figure of ‌1.17 million.

Mohs for Rare Skin Cancer Linked to Lower Recurrence vs WLE

Mohs micrographic surgery reduces positive margins and 5-year recurrence in patients with dermatofibrosarcoma protuberans, compared with wide local excision, study finds.

The Potential for Remission, Cure in Psoriasis

'With the IL-23 blockers, for the first time ever, we've … seen a disconnect between drug levels in the blood and the ability to stay in remission,' says Andrew Blauvelt, MD.

Genital Lesions Most Common Sign of CCD

Most patients with cutaneous Crohn’s disease present with genital lesions and show good response with biologic therapy, according to a study shows.

FDA Approves OTC Switch for Topical Acne Treatment

The product combining adapalene 0.1% and benzoyl peroxide 2.5% was approved as a prescription acne treatment in December 2008 for patients aged 12 years and older.

Botulinum Toxin for Frown Lines Moves Toward EU Approval

EMA advisers have backed a botulinum toxin for moderate to severe frown lines in adults, with reported onset of action as early as 8 hours and effects lasting 2-3 weeks.

Epidermolysis Bullosa: New Therapies Bring Hope, Healing

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.

Expert Guidance on Stacking Systemic Therapies for Psoriasis

Advice on when and how to switch or stack treatments can help in cases of an incomplete or waning response.

Endocrine Disruptors: Could Exposure Affect Generations?

Clinicians are urged to consider cumulative endocrine disruptor exposure in patients with unexplained hormonal and metabolic symptoms.

Recommended News For You

World's premier cancer institute faces crippling cuts and chaos

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

New imaging guidelines for head and neck cancers, a step toward practice change

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

Data indicate 1 in 3 US adults unaware of connection between HPV and cancers

NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.

Recommended Articles For You

Vaccines that can help prevent cancer 

Innovative Advances in Oncology for Specialists 

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

2.

Is global cancer care losing its human touch?

3.

New study links air pollution with higher rates of head and neck cancer

4.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

5.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

1.

Contemporary Trends in Oncology and Patient Outcomes

2.

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies

3.

Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025

4.

Emerging Frameworks in Oncology in Clinical Decision-Making

5.

The Basics of M.C.V Normal Range for Better Health Management

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot